在意大利北部大规模接种COVID-19疫苗之前和之后,COPD相关的死亡率
Ugo Fedeli1, Veronica Casotto1, Claudio Barbiellini Amidei1
1Epidemiological Department, Azienda Zero-Veneto Region, 35131 Padua, Italy.
Vaccines
|August 26, 2023
概括
COVID-19大流行最初增加了慢性阻塞性肺病 (COPD) 死亡率,特别是当COVID-19是潜在原因时. 大规模接种疫苗的努力显著减少了COPD相关的死亡,特别是在老年人中.
科学领域:
- 肺部医学 肺部医学
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 在人口层面上,COVID-19大流行对慢性阻塞性肺病 (COPD) 死亡率的影响在很大程度上是未知的.
- 调查不同流行病波的COPD死亡率趋势以及疫苗接种的影响至关重要.
研究的目的:
- 评估COVID-19流行病对意大利COPD相关死亡率的影响.
- 分析COVID-19疫苗接种活动之前和之后的死亡率趋势,特别是在不同年龄组.
主要方法:
- 意大利维内托地区40岁以上居民的死亡证明分析 (2008-2021年).
- 对COPD的年龄标准化死亡率的计算提到.
- 使用通用估计方程 (GEE) 模型来估计与流行病相关的死亡率趋势,按年龄,并发病和死亡地点分层.
主要成果:
- 与2018-2019年平均水平相比,2020年COPD在14%的死亡证明中被提及.
- 2020年,所有群体的COPD年龄标准化死亡率都增加了;到2021年,老年人死亡率恢复到大流行前的水平,但40-79岁的人死亡率没有增加 (+6%).
- COVID-19是高达35%的COPD死亡的潜在原因,在峰值的流行浪潮期间;并发性糖尿病和高血压显示死亡率略有增加.
结论:
- 由于COVID-19的死亡,COPD的死亡率最初上升.
- 疫苗接种运动与COPD死亡率显著下降相关,特别是在老年人中.
- 大规模疫苗接种在缓解COPD相关死亡病例的流行病后期阶段起着至关重要的作用.
相关概念视频
COPD: Pathogenesis and Clinical Features
337
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
337
COPD: Management Using Bronchodilators and Corticosteroids
244
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
244
Chronic Obstructive Pulmonary Disease
1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Bias in Epidemiological Studies
349
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
349
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K


